Average Co-Inventor Count = 1.20
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genzyme Glycobiology Research Institute Inc. (10 from 10 patents)
2. Genzyme Corporation (1 from 787 patents)
3. The University of Oklahoma (1 from 560 patents)
4. Novazyme Pharmaceuticals, Inc. (1 from 1 patent)
13 patents:
1. 7371366 - GlcNAc phosphotransferase of the lysosomal targeting pathway
2. 7135322 - Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
3. 7067127 - GIcNAc phosphotransferase of the lysosomal targeting pathway
4. 6905856 - Soluble GlcNAc phosphotransferase
5. 6861242 - Methods for producing highly phosphorylated lysosomal hydrolases
6. 6828135 - Phosphodiester &agr;-GlcNAcase of the lysosomal targeting pathway
7. 6800472 - Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester &agr;-N-acetyl glucosimanidase
8. 6770468 - Phosphodiester-a-GlcNAcase of the lysosomal targeting pathway
9. 6670165 - Methods for producing highly phosphorylated lysosomal hydrolases
10. 6642038 - GlcNAc phosphotransferase of the lysosomal targeting pathway
11. 6537785 - Methods of treating lysosomal storage diseases
12. 6534300 - Methods for producing highly phosphorylated lysosomal hydrolases
13. 6492152 - Core 1 &bgr;3-galactosyl transferases and methods of use thereof